|
FANCI expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79422999999623E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.92249999999561E-05 |
| Normal-vs-Stage2 |
4.121600E-02 |
| Normal-vs-Stage3 |
5.31870000042289E-07 |
| Normal-vs-Stage4 |
3.83630000000412E-05 |
| Stage1-vs-Stage2 |
4.882800E-03 |
| Stage1-vs-Stage3 |
2.658600E-01 |
| Stage1-vs-Stage4 |
4.269600E-01 |
| Stage2-vs-Stage3 |
7.152700E-04 |
| Stage2-vs-Stage4 |
4.142000E-03 |
| Stage3-vs-Stage4 |
9.516200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.58259999996735E-06 |
| Normal-vs-AfricanAmerican |
1.141890E-03 |
| Normal-vs-Asian |
1.041540E-04 |
| Caucasian-vs-AfricanAmerican |
5.998600E-01 |
| Caucasian-vs-Asian |
4.248000E-01 |
| AfricanAmerican-vs-Asian |
4.324000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.2772999999976E-05 |
| Normal-vs-Female |
2.12859999999537E-05 |
| Male-vs-Female |
6.560600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.14200000000952E-06 |
| Normal-vs-Age(41-60Yrs) |
5.163900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.51800000000235E-05 |
| Normal-vs-Age(81-100Yrs) |
1.577510E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.516700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.295600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.916200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.437000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.472810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.264600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.626100E-02 |
| Classical-VS-Follicular |
1.0494000000083E-06 |
| Classical-VS-Other |
4.690200E-01 |
| Classical-VS-Normal |
8.77710000013465E-07 |
| Tall-VS-Follicular |
3.67620000000235E-05 |
| Tall-VS-Other |
1.769990E-01 |
| Tall-VS-Normal |
2.40979999999169E-06 |
| Follicular-VS-Other |
4.201600E-01 |
| Follicular-VS-Normal |
4.240300E-02 |
| Other-VS-Normal |
1.451810E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.595280E-04 |
| Normal-vs-N1 |
7.61350000000327E-05 |
| N0-vs-N1 |
4.116800E-01 |
|
|
